Timeline
LondonMetric confirms post-acquisition intentions for Urban Logistics REIT
LondonMetric and Schroder SREIT table £403.4m all‑share proposal for Picton
More in Pharma
Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew
A clinical setback dominated the health and biotech session, as AstraZeneca shed more than 7% after its Phase III CARDIO-TTRansform trial of Wainua in heart disease failed to meet its primary endpoint, the most significant event in an otherwise deal- and financing-focused day for the sector.